Clinical Trial Update: Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow [Phase 2]

View source ↗

Summary

Phase 2 trial of sunitinib in patients with stage I-III breast cancer and tumor cells in the bone marrow was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-05-08